S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(-0.03%) $0.926
USD/NOK
(-0.09%) $10.83
USD/GBP
(-0.12%) $0.791
USD/RUB
(-0.21%) $92.38

Realtime updates for Cyclo Therapeutics, Inc. [CYTH]

Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturersā€”Specialty & Generic
Last Updated28 Mar 2024 @ 16:00

-0.71% $ 1.390

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302
Profile picture for Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease...

Stats
Today's Volume 30 256.00
Average Volume 102 611
Market Cap 39.91M
EPS $0 ( 2024-03-18 )
Next earnings date ( $0 ) 2024-05-13
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.130
ATR14 $0.00400 (0.29%)
Insider Trading
Date Person Action Amount type
2024-02-13 Sieger Markus Buy 14 004 Common Stock
2024-02-13 Ostronic Francis Patrick Buy 8 703 Common Stock
2024-02-13 Toig Randall M. Buy 7 516 Common Stock
2024-02-13 Strattan Ce Rick Buy 6 963 Common Stock
2024-02-13 Wong Vivien Buy 6 330 Common Stock
INSIDER POWER
50.61
Last 99 transactions
Buy: 16 269 213 | Sell: 5 479 045

Volume Correlation

Long: 0.05 (neutral)
Short: -0.12 (neutral)
Signal:(43.987) Neutral

Cyclo Therapeutics, Inc. Correlation

10 Most Positive Correlations
STRO0.944
ASPU0.94
LSXMK0.922
LSXMA0.922
PRTG0.917
NAKD0.917
BOCH0.915
SIRI0.911
ACRX0.91
BFRI0.91
10 Most Negative Correlations
PAE-0.928
RMRM-0.927
APOP-0.916
PESI-0.907
EBSB-0.905
INTA-0.905
LMNR-0.905
NCAC-0.903
NVDA-0.903
FTNT-0.902

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cyclo Therapeutics, Inc. Correlation - Currency/Commodity

The country flag 0.41
( neutral )
The country flag 0.32
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.09
( neutral )

Cyclo Therapeutics, Inc. Financials

Annual 2023
Revenue: $1.08M
Gross Profit: $-2.41M (-223.91 %)
EPS: $-1.230
Q4 2023
Revenue: $311 399
Gross Profit: $-565 153 (-181.49 %)
EPS: $-0.230
Q3 2023
Revenue: $495 477
Gross Profit: $456 710 (92.18 %)
EPS: $-0.290
Q2 2023
Revenue: $117 118
Gross Profit: $97 209.00 (83.00 %)
EPS: $-0.330

Financial Reports:

No articles found.

Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators